| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260400.1 |
AKT inhibitor VIII |
Brain lower grade glioma |
0.04373904 |
Resistant |
| ENSG00000260400.1 |
AKT inhibitor VIII |
Liver hepatocellular carcinoma |
0.039205344 |
Resistant |
| ENSG00000260400.1 |
AKT inhibitor VIII |
Lung squamous cell carcinoma |
0.02306948 |
Resistant |
| ENSG00000260400.1 |
AKT inhibitor VIII |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.000387654 |
Sensitive |
| ENSG00000260400.1 |
AKT inhibitor VIII |
Sarcoma |
0.043992664 |
Sensitive |
